Affordable Access

Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.

Authors
  • Kazderova, Marketa1
  • Jancova, Eva
  • Rysava, Romana
  • Merta, Miroslav
  • Tesar, Vladimir
  • 1 Department of Nephrology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. [email protected] , (Czechia)
Type
Published Article
Journal
Archives of Medical Research
Publisher
Elsevier
Publication Date
Jan 01, 2008
Volume
39
Issue
1
Pages
115–119
Identifiers
PMID: 18068004
Source
Medline
License
Unknown

Abstract

MMF, in the relatively low doses used, was safe and effective, stabilizing or improving AAV in 73% of patients and SLE in 61%. Further prospective randomized controlled trials with MMF in renal vasculitis and lupus nephritis are clearly warranted.

Report this publication

Statistics

Seen <100 times